Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pregabalin naproxencarbil in acute post-bunionectomy pain: a randomized clinical trial.
Journal: Pain reports
Published: September 16, 2025
Suzetrigine, a Nonopioid Na V 1.8 Inhibitor for Treatment of Moderate-to-severe Acute Pain: Two Phase 3 Randomized Clinical Trials.
Journal: Anesthesiology
Published: March 21, 2025
Suzetrigine, a Non-Opioid NaV1.8 Inhibitor With Broad Applicability for Moderate-to-Severe Acute Pain: A Phase 3 Single-Arm Study for Surgical or Non-Surgical Acute Pain.
Journal: Journal of pain research
Published: December 08, 2024
Real-world utilization of once-daily extended-release abuse deterrent formulation of hydrocodone: a comparison with the pre-approval randomized clinical trials.
Journal: Journal of pain research
Published: August 11, 2017
Hysingla® ER, a once-daily, single-entity hydrocodone with abuse-deterrent properties in treating chronic nonmalignant and nonneuropathic pain in patients with osteoarthritis.
Journal: Postgraduate medicine
Published: December 17, 2016
Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.
Journal: Postgraduate medicine
Published: December 19, 2015
12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.
Journal: Journal of opioid management
Published: August 28, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026